Expresses support for designating May 15, 2025, as "Prader-Willi Syndrome Awareness Day" to raise awareness and promote research for this rare genetic disorder.
Paul Tonko
Representative
NY-20
This bill expresses support for designating May 15, 2025, as "Prader-Willi Syndrome Awareness Day" to increase awareness and promote research for this rare genetic disorder. It acknowledges the challenges faced by individuals with PWS and their families, while also recognizing the importance of early diagnosis, research, and the development of new treatments. The bill also praises advocates, organizations, parents, families, researchers, and health professionals for their dedication to finding effective treatments and a cure for PWS.
This resolution throws its support behind designating May 15, 2025, as "Prader-Willi Syndrome Awareness Day." The main goal here is straightforward: to shine a brighter spotlight on Prader-Willi Syndrome (PWS), a complex genetic disorder, and encourage more research into treatments and potential cures.
So, what exactly is PWS? The resolution identifies it as a rare genetic condition affecting roughly 1 in every 15,000 births. It's characterized by a range of challenging symptoms, most notably an insatiable appetite (hyperphagia) that can lead to life-threatening obesity. Beyond that, it often involves physical and intellectual hurdles. A key point highlighted is that currently, there's no known cure, making research critical.
While a resolution like this doesn't create new laws or allocate funding, it serves as an official nod of recognition and support. Think of it as putting a marker on the calendar to focus attention. The text acknowledges that early diagnosis and existing treatments, like human growth hormone, can significantly improve quality of life. By designating an awareness day, the hope is to boost public understanding, encourage earlier detection, and potentially galvanize more support for research efforts and organizations like the Prader-Willi Syndrome Association, which provides resources to affected families.
The resolution also takes a moment to specifically praise the ongoing work of advocates, families, researchers, and healthcare professionals. It recognizes the dedication involved in navigating PWS and searching for better treatments. This official acknowledgment aims to validate their efforts and underscore the importance of continued work in understanding and managing rare diseases, including finding clearer pathways for developing and approving new therapies.